Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
24%
OVERLAP
BY WEIGHT
6
# OF OVERLAPPING
HOLDINGS
IYH
103
HOLDINGS
6%
ALSO IN OZEM
OZEM
22
HOLDINGS
29%
ALSO IN IYH
SECTOR DRIFT (IYH minus OZEM)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IYH |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
| ELI LILLY & CO | 14.2% | 17.0% | 14.2% | |
| AMGEN INC | 3.5% | 4.0% | 3.5% | |
| PFIZER INC | 2.7% | 7.1% | 2.7% | |
| GILEAD SCIENCES INC | 3.2% | 2.0% | 2.0% | |
| REGENERON PHARMACEUTICALS | 1.4% | 3.2% | 1.4% | |
IYH Overweight Relative to OZEM
| JOHNSON & JOHNSON | 10.4% | |
| ABBVIE INC | 7.0% | |
| MERCK & CO. INC. | 5.2% | |
| UNITEDHEALTH GROUP INC | 4.6% | |
| ABBOTT LABORATORIES | 3.4% | |
| THERMO FISHER SCIENTIFIC INC | 3.1% | |
| INTUITIVE SURGICAL INC | 3.0% | |
| VERTEX PHARMACEUTICALS INC | 2.2% | |
| BRISTOL-MYERS SQUIBB CO | 2.2% | |
| DANAHER CORP | 2.1% |
IYH Underweight Relative to OZEM
| NOVO-NORDISK A/S-SPONS ADR | -13.4% | |
| VIKING THERAPEUTICS, INC. | -5.6% | |
| INNOVENT BIOLOGICS, INC. | -4.8% | |
| PFIZER INC | -4.3% | |
| ASCLETIS PHARMA, INC. | -4.1% | |
| ROCHE HOLDING LTD | -4.0% | |
| CHUGAI PHARMACEUTICAL CO LTD | -3.7% | |
| ASTRAZENECA PLC | -3.6% | |
| HANMI PHARM CO LTD | -3.5% | |
| ZEALAND PHARMA A/S | -3.2% |